Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124784434 | 12478443 | 4 | F | 20160614 | 20160725 | 20160618 | 20160726 | EXP | AU-JNJFOC-20160614087 | PHARMACYCLICS | 82.64 | YR | Y | 76.30000 | KG | 20160726 | MD | AU | AU |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124784434 | 12478443 | 1 | PS | IBRUTINIB | IBRUTINIB | 1 | Oral | N | N | 205552 | 560 | MG | CAPSULE | QD | |||||
124784434 | 12478443 | 2 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Intravenous (not otherwise specified) | EVERY 21 DAYS | 0 | 760 | MG | POWDER FOR INJECTION | |||||||
124784434 | 12478443 | 3 | SS | DOXORUBICIN | DOXORUBICIN | 1 | Intravenous (not otherwise specified) | EVERY 21 DAYS | 0 | 47 | MG | SOLUTION | |||||||
124784434 | 12478443 | 4 | SS | VINCRISTINE | VINCRISTINE | 1 | Intravenous (not otherwise specified) | EVERY 21 DAYS | 0 | 1 | MG | SOLUTION | |||||||
124784434 | 12478443 | 5 | SS | PREDNISONE. | PREDNISONE | 1 | Oral | 0 | 100 | MG | TABLET | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
124784434 | 12478443 | 1 | Diffuse large B-cell lymphoma |
124784434 | 12478443 | 2 | Diffuse large B-cell lymphoma |
124784434 | 12478443 | 3 | Diffuse large B-cell lymphoma |
124784434 | 12478443 | 4 | Diffuse large B-cell lymphoma |
124784434 | 12478443 | 5 | Diffuse large B-cell lymphoma |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
124784434 | 12478443 | LT |
124784434 | 12478443 | DE |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
124784434 | 12478443 | Acute pulmonary oedema | |
124784434 | 12478443 | Arrhythmia | |
124784434 | 12478443 | Atelectasis | |
124784434 | 12478443 | Atrial fibrillation | |
124784434 | 12478443 | Blood albumin decreased | |
124784434 | 12478443 | Blood calcium decreased | |
124784434 | 12478443 | Blood chloride decreased | |
124784434 | 12478443 | Blood magnesium increased | |
124784434 | 12478443 | Blood phosphorus increased | |
124784434 | 12478443 | Blood urea increased | |
124784434 | 12478443 | Cardiac arrest | |
124784434 | 12478443 | Delirium | |
124784434 | 12478443 | Fall | |
124784434 | 12478443 | Febrile neutropenia | |
124784434 | 12478443 | Glomerular filtration rate decreased | |
124784434 | 12478443 | Mucosal inflammation | |
124784434 | 12478443 | Myocardial infarction | |
124784434 | 12478443 | Pleural effusion | |
124784434 | 12478443 | Pulmonary congestion | |
124784434 | 12478443 | Tendon rupture |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
124784434 | 12478443 | 1 | 20160611 | 20160619 | 0 | |
124784434 | 12478443 | 2 | 20160611 | 20160611 | 0 | |
124784434 | 12478443 | 3 | 20160611 | 20160611 | 0 | |
124784434 | 12478443 | 4 | 20160611 | 20160611 | 0 | |
124784434 | 12478443 | 5 | 20160611 | 20160611 | 0 |